-
-
No events on calendar for this bill.
-
Ch. SL 2021-29Senate06/11/2021Signed by Gov. 6/11/2021Senate06/11/2021Pres. To Gov. 6/4/2021Senate06/04/2021RatifiedSenate06/03/2021Ordered EnrolledHouse06/02/2021Passed 3rd ReadingHouse06/02/2021Passed 2nd ReadingHouse06/02/2021Added to CalendarHouse06/02/2021Cal Pursuant Rule 36(b)House06/02/2021Reptd FavHouse06/02/2021Re-ref Com On Rules, Calendar, and Operations of the HouseHouse05/25/2021Reptd FavHouse05/25/2021Re-ref to the Com on Health, if favorable, Rules, Calendar, and Operations of the HouseHouse05/24/2021Withdrawn From ComHouse05/24/2021Ref To Com On Rules, Calendar, and Operations of the HouseHouse05/10/2021Passed 1st ReadingHouse05/10/2021Regular Message Received From SenateHouse05/06/2021Regular Message Sent To HouseSenate05/06/2021Passed 3rd ReadingSenate05/05/2021Passed 2nd ReadingSenate05/05/2021Reptd FavSenate05/04/2021Re-ref Com On Rules and Operations of the SenateSenate04/28/2021Reptd FavSenate04/28/2021Re-ref to Health Care. If fav, re-ref to Rules and Operations of the SenateSenate04/19/2021Withdrawn From ComSenate04/19/2021Ref To Com On Rules and Operations of the SenateSenate04/07/2021Passed 1st ReadingSenate04/07/2021FiledSenate04/06/2021
-
FiledNo fiscal notes available.Edition 1No fiscal notes available.RatifiedNo fiscal notes available.SL 2021-29No fiscal notes available.
-
COMMISSIONS
DISEASES & HEALTH DISORDERS
GENERAL ASSEMBLY
LEGISLATIVE RESEARCH COMN.
PRESENTED
PUBLIC
PUBLIC HEALTH
RATIFIED
REPORTS
STUDIES
WOMEN
CHAPTERED
-
-
No counties specifically cited.
-
-
-
S586: Study Lipedema. Latest Version
2021-2022
GENERAL ASSEMBLY OF NORTH CAROLINA
SESSION 2021
SESSION LAW 2021-29
SENATE BILL 586
AN ACT to direct the legislative research commission to study lipedema.
The General Assembly of North Carolina enacts:
SECTION 1.(a) The Legislative Research Commission (LRC) shall study the medical issues surrounding lipedema and the impact of this disease on women residing in North Carolina.
As part of its study, the LRC shall do all of the following:
(1) Examine the number of women who have been diagnosed with lipedema over the last five years and the symptoms associated with the disease.
(2) Examine the number of women with lipedema who have been misdiagnosed or underdiagnosed over the last five years.
(3) Examine the causes and cures for lipedema.
(4) Identify effective therapies for managing the symptoms associated with lipedema and whether these therapies are affordable and readily available within the State.
(5) Examine whether lipedema disproportionately affects a particular population of women in the State.
(6) Any other matters the LRC deems relevant to its efforts.
SECTION 1.(b) The LRC shall report its findings, together with any proposed legislation, to the 2022 Regular Session of the 2021 General Assembly upon its convening.
SECTION 2. This act is effective when it becomes law.
In the General Assembly read three times and ratified this the 3rd day of June, 2021.
s/ Phil Berger
President Pro Tempore of the Senate
s/ Tim Moore
Speaker of the House of Representatives
s/ Roy Cooper
Governor
Approved 1:07 p.m. this 11th day of June, 2021